Table 1.
Characteristics of the Patients Enrolled in the Study
| Diabetic Patients, n=20 | Nondiabetic Patients, n=20 | |
|---|---|---|
| Sex, M/F | 10/10 | 10/10 |
| Age, y | 64.3±2.1 | 62.6±2.3 |
| Duration of diabetes, y | 9.2±1.1 | — |
| BMI, kg/m2 | 28.9±0.9 | 27.2±0.7 |
| HbA1c, % | 7.2±0.1 | 5.3±0.1* |
| FBG, mg/dL | 151.3±9.5 | 81.5±3.9* |
| LDL cholesterol, mg/dL | 132.3±7.1 | 128±5.1 |
| HDL cholesterol, mg/dL | 43.3±1.6 | 48.2±1.8* |
| TG, mg/dL | 167.5±10.3 | 126±8.5* |
| SBP, mm Hg | 133.9±3.7 | 127.3±3.2 |
| DBP, mm Hg | 76.3±2.1 | 74.1±2.4 |
| Three‐vessel CHD, n | 18 | 18 |
| Two‐vessel CHD, n | 2 | 2 |
| Therapy, n | ||
| Statins | 16 | 16 |
| Aspirin | 20 | 20 |
| β‐Blockers | 8 | 9 |
| ACEIs/ARBs | 15 | 14 |
| Nitrates | 16 | 15 |
Quantitative data are expressed as mean±SE. Binary data are reported by counts. *P<0.01 vs diabetic patients. Comparisons of the quantitative data have been made through use of Student's t test for independent samples. The χ2 test was used to compare binary data. BMI indicates body mass index; FBG, fasting blood glucose; LDL, low‐density lipoprotein; HDL, high‐density lipoprotein; TG, triglycerides; SDP, systolic blood pressure; DBP, diastolic blood pressure; CHD, coronary heart disease; ACEI, angiotensin‐converting enzyme‐inhibitor; ARB, angiotensin II receptor blocker.